journal article·2026-03Open access

Identification of a Force‐Induced Sox9 + Acan + Transitional Subpopulation Linked to FGF2–FGFR2–ERK Signaling in Orthodontic Bone Remodeling

Miao Tan, Minyu He, Mingrui Zong, Qiya Tang, Yinan Liu, Jiaju Deng, Shun Huang, Xiaoxiao Lei, Jie Li, Lan Huang

Advanced Science· Volume 13· Issue 18

Abstract

ABSTRACT Orthodontic tooth movement (OTM) under excessive force is often accompanied by orthodontically induced inflammatory root resorption (OIIRR). Multiple cell types and pathways contribute, yet the heterogeneity of mesenchymal lineage cells remains poorly defined. Murine models of OTM are established, and single‐cell RNA sequencing (scRNA‐seq) is performed to profile force‐induced transcriptional dynamics. Mesenchymal lineage cells are resolved into five subsets, including mesenchymal stem cells, cementoblasts, osteoblasts, fibroblasts, and a previously unrecognized cluster co‐expressing Sox9 and Acan. Functional validation by RNAscope, multiplex immunohistochemistry, and mechanostimulation confirms the localization and activity of this subpopulation. scRNA‐seq also identifies 14 additional cell types, including immune and mesenchymal populations. Reclustering of macrophages reveals gene programs associated with bone resorption. Sox9 + Acan + cells exemplify a mechanosensitive transitional population that integrates biomechanical stress with osteoimmune regulation, a paradigm relevant to skeletal mechanobiology. These cells interact with Mmp14 + macrophages to activate FGF2–FGFR2–ERK signaling, thereby enhancing osteoclast differentiation and bone resorption. A GelMA@siRNA hydrogel system for localized delivery of Sox9‐targeting siRNA silences Sox9 expression in vivo, suppresses osteoclast activity, reduces root resorption, and modulates tooth movement. Together, these findings identify Sox9 + Acan + cells as a force‐sensitive regulatory node in skeletal biology and propose a therapeutic strategy to mitigate OIIRR.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: dental development and anomalies · Bone Metabolism and Diseases · Orthodontics and Dentofacial Orthopedics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Stomatology Chongqing Medical University Chongqing P. R. China

Chongqing Key Laboratory of Oral Diseases Chongqing Medical University Chongqing P. R. China

Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education Chongqing Medical University Chongqing P. R. China

Chongqing Municipal Health Commission Key Laboratory of Oral Biomedical Engineering Chongqing Medical University Chongqing P. R. China

Funding

Natural Science Foundation of Chongqing Municipality · Chongqing Municipal Science and Technology Bureau · National Natural Science Foundation of China

References (57)

Show source-provided references
1. 10.3390/ijms2205238810.3390/ijms22052388 ↗
2. 10.1043/0003‐3219(2002)072<0175:OIIRRP>2.0.CO;210.1043/0003‐3219(2002)072<0175:OIIRRP>2.0.CO;2 ↗
3. 10.1038/s41368‐021‐00125‐510.1038/s41368‐021‐00125‐5 ↗
4. 10.1093/ejo/cjaa05810.1093/ejo/cjaa058 ↗
5. 10.1016/j.ajodo.2005.12.01310.1016/j.ajodo.2005.12.013 ↗
6. 10.3389/fimmu.2022.83598610.3389/fimmu.2022.835986 ↗
7. 10.1177/0022034525133458310.1177/00220345251334583 ↗
8. 10.1177/002203452098477410.1177/0022034520984774 ↗
9. 10.1002/advs.20241615910.1002/advs.202416159 ↗
10. 10.1002/advs.20240252910.1002/advs.202402529 ↗
11. 10.1038/s41413‐021‐00141‐510.1038/s41413‐021‐00141‐5 ↗
12. 10.1038/s41368‐023‐00246‐z10.1038/s41368‐023‐00246‐z ↗
13. 10.1177/0022034521104978510.1177/00220345211049785 ↗
14. 10.1016/j.devcel.2020.06.00610.1016/j.devcel.2020.06.006 ↗
15. 10.1093/jbmr/zjae15210.1093/jbmr/zjae152 ↗
16. 10.1038/s41413‐024‐00345‐510.1038/s41413‐024‐00345‐5 ↗
17. 10.1038/s41368‐021‐00150‐410.1038/s41368‐021‐00150‐4 ↗
18. 10.1177/0022034523115982110.1177/00220345231159821 ↗
19. 10.3389/fcell.2022.79544110.3389/fcell.2022.795441 ↗
20. 10.1186/s12915‐024‐01996‐w10.1186/s12915‐024‐01996‐w ↗
21. 10.1186/s10020‐024‐00904‐w10.1186/s10020‐024‐00904‐w ↗
22. 10.1111/jcpe.1398210.1111/jcpe.13982 ↗
23. 10.7150/thno.6569410.7150/thno.65694 ↗
24. 10.1177/0022034522114590310.1177/00220345221145903 ↗
25. 10.1111/prd.1261910.1111/prd.12619 ↗
26. 10.1177/0022034521100184810.1177/00220345211001848 ↗
27. 10.1111/odi.1476110.1111/odi.14761 ↗
28. 10.3389/fimmu.2024.136327810.3389/fimmu.2024.1363278 ↗
29. 10.1002/smtd.20210075210.1002/smtd.202100752 ↗
30. 10.1016/bs.ctdb.2019.01.00710.1016/bs.ctdb.2019.01.007 ↗
31. 10.1016/j.devcel.2011.12.02410.1016/j.devcel.2011.12.024 ↗
32. 10.1016/j.celrep.2022.11173710.1016/j.celrep.2022.111737 ↗
33. 10.1038/s41467‐025‐59206‐210.1038/s41467‐025‐59206‐2 ↗
34. 10.1002/stem.328810.1002/stem.3288 ↗
35. 10.1002/jcp.2803510.1002/jcp.28035 ↗
36. 10.1007/s10266‐013‐0142‐110.1007/s10266‐013‐0142‐1 ↗
37. 10.1074/jbc.M111.27491010.1074/jbc.M111.274910 ↗
38. 10.1590/2176‐9451.19.3.067‐074.oar10.1590/2176‐9451.19.3.067‐074.oar ↗
39. 10.1074/jbc.M91013219910.1074/jbc.M910132199 ↗
40. 10.3389/fimmu.2024.142805910.3389/fimmu.2024.1428059 ↗
41. 10.1177/002203451877133110.1177/0022034518771331 ↗
42. 10.1210/endrev/bnad02510.1210/endrev/bnad025 ↗
43. 10.3390/cells909207310.3390/cells9092073 ↗
44. 10.1038/s41584‐021‐00673‐410.1038/s41584‐021‐00673‐4 ↗
45. 10.1038/nrrheum.2014.16410.1038/nrrheum.2014.164 ↗
46. 10.1007/s11914‐024‐00869‐z10.1007/s11914‐024‐00869‐z ↗
47. 10.1016/S0140‐6736(14)60802‐310.1016/S0140‐6736(14)60802‐3 ↗
48. 10.1016/S0895‐3988(08)60060‐410.1016/S0895‐3988(08)60060‐4 ↗
49. 10.1007/s00198007011110.1007/s001980070111 ↗
50. 10.1111/odi.1323910.1111/odi.13239 ↗
51. 10.3390/pharmaceutics1608098410.3390/pharmaceutics16080984 ↗
52. 10.1021/acsnano.3c0338510.1021/acsnano.3c03385 ↗
53. 10.1093/rb/rbaf11510.1093/rb/rbaf115 ↗
54. 10.1016/j.ijbiomac.2025.14623410.1016/j.ijbiomac.2025.146234 ↗
55. 10.1016/j.ijpharm.2025.12585010.1016/j.ijpharm.2025.125850 ↗
56. 10.7150/thno.10372510.7150/thno.103725 ↗
57. 10.1002/advs.20220504110.1002/advs.202205041 ↗